None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Adult patients whose age is over 19 years of age and whose jaw growth has been completed ? If you have or have been given a medication that can cause jaw necrosis:IV Bisphosphonate, Denosumab, Angiogenesis inhibitor, etc.Oral use for more than 2 years have been diagnosed with osteonecrosis of the jaw amd have undergone bone resection surgery, then 6 months after complete recovery ? Patients who agreed to participate in the clinical trial and signed the patient consent form
Exclusion criteria
Exclusion criteria: ? If there is a history of radiation therapy in the head and neck, including jaw, or a malignant tumor of the jaw area ? Patients who unctrolled systemic disease, including hemorrhagic diseases ? Patients who have hypersensitivity to implant, metal plate materials, or implant materials ? Patients requiring extensive bone grafting ? Patients who have severe oral and jaw habits(bruxism, clenching) ? If the investigator determines that participation in the clinical trial is inappropriate because it may affect other ethical or clinical trial results. ? Patients who find implant placement surgery difficult (uncooperative patients, cases with very poor oral hygiene management, etc.) ? Patients who do not understand the purpose of the research and do not agree
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Initial stability (measured by RFA levels);Long-term stability (marginal bone resorption) | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical characteristic / Demographic evaluation;Radiation examination | — |
Countries
Korea, Republic of
Contacts
Ewha Womens University